{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T13:39:37Z","timestamp":1759412377998},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,7,30]],"date-time":"2015-07-30T00:00:00Z","timestamp":1438214400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12879-015-1015-8","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T12:13:00Z","timestamp":1438171980000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The impact of aggregating serogroups in dynamic models of Neisseria meningitidis transmission"],"prefix":"10.1186","volume":"15","author":[{"given":"Keith D","family":"Poore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris T","family":"Bauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"1015_CR1","unstructured":"WHO | Meningococcal Meningitis [ http:\/\/www.who.int\/mediacentre\/factsheets\/fs141\/en\/ ]"},{"key":"1015_CR2","doi-asserted-by":"crossref","unstructured":"Vickers, DM, Anonychuk, AM, De Wals, P, Demarteau, N, Bauch, CT. Evaluation of serogroup C and ACWY meningococcal vaccine programs: projected impact on disease burden according to a stochastic 2-strain dynamic model. Vaccine 2014, in press.","DOI":"10.1016\/j.vaccine.2013.09.034"},{"issue":"12","key":"1015_CR3","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1016\/S1473-3099(10)70251-6","volume":"10","author":"H Christensen","year":"2010","unstructured":"Christensen H, May M, Bowen L, Hickman M, Trotter CL. Meningococcal carriage by age: a systematic review and meta-analysis. Lancet Infect Dis. 2010;10(12):853\u201361.","journal-title":"Lancet Infect Dis"},{"key":"1015_CR4","unstructured":"PHAC Invasive Meningococcal Disease for Health Professionals [ http:\/\/www.phac-aspc.gc.ca\/im\/vpd-mev\/meningococcal\/professionals-professionnels-eng.php ]"},{"issue":"2","key":"1015_CR5","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1128\/JCM.32.2.323-330.1994","volume":"32","author":"DA Caugant","year":"1994","unstructured":"Caugant DA, H\u00f8iby EA, Magnus P, Scheel O, Hoel T, Bjune G, et al. Asymptomatic carriage of Neisseria meningitidis in a randomly sampled population. J Clin Microbiol. 1994;32(2):323\u201330.","journal-title":"J Clin Microbiol"},{"issue":"1","key":"1015_CR6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/oxfordjournals.aje.a120532","volume":"82","author":"JR Gauld","year":"1965","unstructured":"Gauld JR, Nitz RE, Hunter DH, Rust JH, Gauld RL. Epidemiology of meningococcal meningitis at Fort Ord. Am J Epidemiol. 1965;82(1):56\u201372.","journal-title":"Am J Epidemiol"},{"issue":"2","key":"1015_CR7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1097\/00006454-198603000-00011","volume":"5","author":"PJ Hudson","year":"1986","unstructured":"Hudson PJ, Vogt RL, Heun EM, Brondum J, Coffin RR, Plikaytis BD, et al. Evidence for school transmission of Neisseria meningitidis during a Vermont outbreak. Pediatr Infect Dis J. 1986;5(2):213\u20137.","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"1015_CR8","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1093\/infdis\/129.6.644","volume":"129","author":"RS Munford","year":"1974","unstructured":"Munford RS, de Vasconcelos ZJS, Phillips CJ, Gelli DS, Gorman GW, Risi JB, et al. Eradication of carriage of Neisseria meningitidis in families: A study in Brazil. J Infect Dis. 1974;129(6):644\u20139.","journal-title":"J Infect Dis"},{"issue":"2","key":"1015_CR9","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3109\/inf.1981.13.issue-2.05","volume":"13","author":"P Olcen","year":"1981","unstructured":"Olcen P, Kjellander J, Danielsson D, Lindquist BL. Epidemiology of Neisseria meningitidis; prevalence and symptoms from the upper respiratory tract in family members to patients with meningococcal disease. Scand J Infect Dis. 1981;13(2):105.","journal-title":"Scand J Infect Dis"},{"issue":"5","key":"1015_CR10","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1001\/jama.1997.03540290041030","volume":"277","author":"KM Zangwill","year":"1997","unstructured":"Zangwill KM, Schuchat A, Riedo FX, Pinner RW, Koo DT, Reeves MW, et al. School-based clusters of meningococcal disease in the united states. JAMA. 1997;277(5):389\u201395.","journal-title":"JAMA"},{"issue":"1","key":"1015_CR11","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1111\/j.1574-695X.1999.tb01267.x","volume":"24","author":"J Kremastinou","year":"1999","unstructured":"Kremastinou J, Tzanakaki G, Pagalis A, Theodondou M, Weir DM, Blackwell C. Detection of igg and igm to meningococcal outer membrane proteins in relation to carriage of Neisseria meningitidis or Neisseria lactamica. FEMS Immunol Med Microbiol. 1999;24(1):73\u20138.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"1015_CR12","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1111\/j.1574-695X.2000.tb01419.x","volume":"27","author":"G Troncoso","year":"2000","unstructured":"Troncoso G, Sanchez S, Moreda M, Criado MT, Ferreiros CM. Antigenic cross-reactivity between outer membrane proteins of Neisseria meningitidis and commensal neisseria species. FEMS Immunol Med Microbiol. 2000;27(2):103\u20139.","journal-title":"FEMS Immunol Med Microbiol"},{"issue":"2","key":"1015_CR13","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1093\/infdis\/137.2.112","volume":"137","author":"R Gold","year":"1978","unstructured":"Gold R, Goldschneider I, Lepow ML, Draper TF, Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis. 1978;137(2):112\u201321.","journal-title":"J Infect Dis"},{"issue":"17","key":"1015_CR14","doi-asserted-by":"publisher","first-page":"2210","DOI":"10.1016\/j.vaccine.2005.01.055","volume":"23","author":"A Gorringe","year":"2005","unstructured":"Gorringe A, Halliwell D, Matheson M, Reddin K, Finney M, Hudson M. The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles. Vaccine. 2005;23(17):2210\u20133.","journal-title":"Vaccine"},{"issue":"1","key":"1015_CR15","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1093\/cid\/ciq065","volume":"52","author":"CM Evans","year":"2011","unstructured":"Evans CM, Pratt CB, Matheson M, Vaughan TE, Findlow J, Borrow R, et al. Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis. Clin Infect Dis. 2011;52(1):70\u20137.","journal-title":"Clin Infect Dis"},{"issue":"6","key":"1015_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/S1286-4579(00)00356-7","volume":"2","author":"YL Tzeng","year":"2000","unstructured":"Tzeng YL, Stephens DS. Epidemiology and pathogenesis of Neisseria meningitidis. Microbes Infect. 2000;2(6):687\u2013700.","journal-title":"Microbes Infect"},{"issue":"19","key":"1015_CR17","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.1001\/jama.280.19.1685","volume":"280","author":"NE MacDonald","year":"1998","unstructured":"MacDonald NE, Halperin SA, Law BJ, Forrest B, Danzig LE, Granoff DM. Induction of immunologic memory by conjugated vs plain meningococcal c polysaccharide vaccine in toddlers. JAMA. 1998;280(19):1685\u20139.","journal-title":"JAMA"},{"issue":"4","key":"1015_CR18","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1155\/2005\/805454","volume":"16","author":"N MacDonald","year":"2005","unstructured":"MacDonald N. Immunization update 2005: Stepping forward. Can J Infect Dis Med Microbiol. 2005;16(4):219.","journal-title":"Can J Infect Dis Med Microbiol"},{"issue":"11","key":"1015_CR19","doi-asserted-by":"publisher","first-page":"1735","DOI":"10.1016\/j.vaccine.2009.01.026","volume":"27","author":"M Kinlin","year":"2009","unstructured":"Kinlin M, Jamieson F, Brown EM, Brown S, Rawte P, Dolman S, et al. Rapid identification of herd effects with the introduction of serogroup c meningococcal conjugate vaccine in ontario, canada, 2000\u20132006. Vaccine. 2009;27(11):1735\u201340.","journal-title":"Vaccine"},{"key":"1015_CR20","unstructured":"PHAC Statement on conjugate meningococcal vaccine for serogroups A, C, Y, and W-135 [ http:\/\/www.phac-aspc.gc.ca\/publicat\/ccdr-rmtc\/07vol33\/acs-03\/index-eng.php ]"},{"key":"1015_CR21","unstructured":"PHAC The recommended use of the multicomponent meningococcal B (4CMenB) vaccine in Canada [ http:\/\/www.phac-aspc.gc.ca\/naci-ccni\/mening-4cmenb-exec-resum-eng.php ]"},{"issue":"16","key":"1015_CR22","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1056\/NEJMra0906357","volume":"362","author":"LKK Tan","year":"2010","unstructured":"Tan LKK, Carlone GM, Borrow R. Advances in the development of vaccines against Neisseria meningitidis. New Engl J Med. 2010;362(16):1511\u201320.","journal-title":"New Engl J Med"},{"issue":"2","key":"1015_CR23","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/S1473-3099(09)70324-X","volume":"10","author":"M Sadarangani","year":"2010","unstructured":"Sadarangani M, Pollard AJ. Serogroup B meningococcal vaccines\u2014an unfinished story. Lancet Infect Dis. 2010;10(2):112\u201324.","journal-title":"Lancet Infect Dis"},{"issue":"17","key":"1015_CR24","doi-asserted-by":"publisher","first-page":"2206","DOI":"10.1016\/j.vaccine.2005.01.056","volume":"23","author":"S Pillai","year":"2005","unstructured":"Pillai S, Howell A, Alexander K, Bentley BE, Jiang HQ, Ambrose K, et al. Outer membrane protein (omp) based vaccine for Neisseria meningitidis serogroup b. Vaccine. 2005;23(17):2206\u20139.","journal-title":"Vaccine"},{"issue":"29","key":"1015_CR25","doi-asserted-by":"publisher","first-page":"10834","DOI":"10.1073\/pnas.0603940103","volume":"103","author":"MM Giuliani","year":"2006","unstructured":"Giuliani MM, Adu-Bobie J, Comanducci M, Aric\u00f2 B, Savino S, Santini L, et al. A universal vaccine for serogroup B meningococcus. Proc Natl Acad Sci. 2006;103(29):10834\u20139.","journal-title":"Proc Natl Acad Sci"},{"issue":"5","key":"1015_CR26","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1016\/S1473-3099(13)70006-9","volume":"13","author":"U Vogel","year":"2013","unstructured":"Vogel U, Taha MK, Vazquez JA, Findlow J, Claus H, Stefanelli P, et al. Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis. 2013;13(5):416\u201325.","journal-title":"Lancet Infect Dis"},{"issue":"7","key":"1015_CR27","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.vaccine.2012.12.022","volume":"31","author":"E Hong","year":"2013","unstructured":"Hong E, Giuliani MM, Deghmane AE, Comanducci M, Brunelli B, Dull P, et al. Could the multicomponent meningococcal serogroup B vaccine (4CMenB) control Neisseria meningitidis capsular group X outbreaks in Africa? Vaccine. 2013;31(7):1113\u20136.","journal-title":"Vaccine"},{"issue":"1","key":"1015_CR28","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1093\/ije\/29.1.180","volume":"29","author":"PG Coen","year":"2000","unstructured":"Coen PG, Cartwright K, Stuart J. Mathematical modelling of infection and disease due to Neisseria meningitidis and Neisseria lactamica. Int J Epidemiol. 2000;29(1):180\u20138.","journal-title":"Int J Epidemiol"},{"issue":"1","key":"1015_CR29","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/1471-2458-7-130","volume":"7","author":"JJ Caro","year":"2007","unstructured":"Caro JJ, M\u00f6ller J, Getsios D, Coudeville L, El-Hadi W, Chevat C, et al. Invasive meningococcal disease epidemiology and control measures: a framework for evaluation. BMC Public Health. 2007;7(1):130.","journal-title":"BMC Public Health"},{"issue":"9431","key":"1015_CR30","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/S0140-6736(04)16725-1","volume":"364","author":"CCL Trotter","year":"2004","unstructured":"Trotter CCL, Andrews NJ, Kaczmarski EB, Miller E, Ramsay ME. Effectiveness of meningococcal serogroup C conjugate vaccine 4 years after introduction. Lancet. 2004;364(9431):365\u20137.","journal-title":"Lancet"},{"issue":"1","key":"1015_CR31","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1093\/aje\/kwi160","volume":"162","author":"CL Trotter","year":"2005","unstructured":"Trotter CL, Gay NJ, Edmunds WJ. Dynamic models of meningococcal carriage, disease, and the impact of serogroup C conjugate vaccination. Am J Epidemiol. 2005;162(1):89\u2013100.","journal-title":"Am J Epidemiol"},{"issue":"27","key":"1015_CR32","doi-asserted-by":"publisher","first-page":"10229","DOI":"10.1073\/pnas.0400695101","volume":"101","author":"N Stollenwerk","year":"2004","unstructured":"Stollenwerk N, Maiden MCJ, Jansen VAA. Diversity in pathogenicity can cause outbreaks of meningococcal disease. Proc Natl Acad Sci U S A. 2004;101(27):10229\u201334.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"33","key":"1015_CR33","doi-asserted-by":"publisher","first-page":"5473","DOI":"10.1016\/j.vaccine.2010.05.056","volume":"28","author":"N Velde Van de","year":"2010","unstructured":"Van de Velde N, Brisson M, Boily MC. Understanding differences in predictions of HPV vaccine effectiveness: A comparative model-based analysis. Vaccine. 2010;28(33):5473\u201384.","journal-title":"Vaccine"},{"issue":"31","key":"1015_CR34","doi-asserted-by":"publisher","first-page":"11802","DOI":"10.1073\/pnas.0602960103","volume":"103","author":"HJ Wearing","year":"2006","unstructured":"Wearing HJ, Rohani P. Ecological and immunological determinants of dengue epidemics. Proc Nat Acad Sci USA. 2006;103(31):11802\u20137.","journal-title":"Proc Nat Acad Sci USA"},{"issue":"8","key":"1015_CR35","doi-asserted-by":"publisher","first-page":"e1003169","DOI":"10.1371\/journal.pcbi.1003169","volume":"9","author":"C Poletto","year":"2013","unstructured":"Poletto C, Meloni S, Colizza V, Moreno Y, Vespignani A. Host mobility drives pathogen competition in spatially structured population. PLoS Comput Biol. 2013;9(8):e1003169.","journal-title":"PLoS Comput Biol"},{"issue":"10","key":"1015_CR36","doi-asserted-by":"publisher","first-page":"e7426","DOI":"10.1371\/journal.pone.0007426","volume":"4","author":"S Ballesteros","year":"2009","unstructured":"Ballesteros S, Vergu E, Cazelles B. Influenza A gradual and epochal evolution: insight from simple models. PLoS One. 2009;4(10):e7426.","journal-title":"PLoS One"},{"issue":"3","key":"1015_CR37","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1137\/S003613990343882X","volume":"65","author":"M Nu\u00f1o","year":"2005","unstructured":"Nu\u00f1o M, Feng Z, Martcheva M, Castillo-Chavez C. Dynamics of two-strain influenza with isolation and partial cross-immunity. SIAM J Appl Math. 2005;65(3):964\u201382.","journal-title":"SIAM J Appl Math"},{"issue":"1","key":"1015_CR38","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1080\/00207160701769625","volume":"86","author":"AB Gumel","year":"2009","unstructured":"Gumel AB. Global dynamics of a two-strain avian influenza model. Int J Comput Math. 2009;86(1):85\u2013108.","journal-title":"Int J Comput Math"},{"key":"1015_CR39","unstructured":"Statistics Canada Table 3\u20131 Deaths by single year of age and geography \u2013 Both sexes [ http:\/\/www.statcan.gc.ca\/pub\/84f0211x\/2009000\/t014-eng.htm ]"},{"issue":"3","key":"1015_CR40","doi-asserted-by":"publisher","first-page":"e74","DOI":"10.1371\/journal.pmed.0050074","volume":"5","author":"J Mossong","year":"2008","unstructured":"Mossong J, Hens N, Jit M, Beutels P, Auranen K, Mikolajczyk R, et al. Social contacts and mixing patterns relevant to the spread of infectious diseases. PLoS Med. 2008;5(3):e74.","journal-title":"PLoS Med"},{"issue":"4","key":"1015_CR41","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1093\/ije\/14.4.628","volume":"14","author":"P Wals De","year":"1985","unstructured":"De Wals P, Bouckaert A. Methods of estimating the duration of bacterial carriage. Int J Epidemiol. 1985;14(4):628\u201343.","journal-title":"Int J Epidemiol"},{"issue":"6","key":"1015_CR42","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1084\/jem.129.6.1327","volume":"129","author":"I Goldschneider","year":"1969","unstructured":"Goldschneider I, Gotschlich EC, Artenstein MS. Human immunity to meningococcus: development of natural immunity. J Exp Med. 1969;129(6):1327\u201348.","journal-title":"J Exp Med"},{"key":"1015_CR43","unstructured":"Bradet R, Audet D, Deceuninck G. Enqu\u00eate sur la couverture vaccinale des enfants de 1 an et 2 ans au Qu\u00e9bec en 2008. Institut national de sant\u00e9 publique du Qu\u00e9bec, Direction des risques biologiques et de la sant\u00e9 au travail, 2009."},{"key":"1015_CR44","volume-title":"Advice for the use of the Multicomponent Meningococcal Serogroup B (4CMenB) Vaccine","author":"An Advidory Committee Statement (ACS) National Advisory Committee on Immunization (NACI)","year":"2014","unstructured":"An Advidory Committee Statement (ACS) National Advisory Committee on Immunization (NACI). Advice for the use of the Multicomponent Meningococcal Serogroup B (4CMenB) Vaccine. 2014."},{"issue":"2","key":"1015_CR45","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/0045-9380(84)90016-1","volume":"14","author":"J Cherry","year":"1984","unstructured":"Cherry J. The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United State: A Comparative study. Curr Probl Pediatr. 1984;14(2):7\u201377.","journal-title":"Curr Probl Pediatr"},{"issue":"1","key":"1015_CR46","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/BF03405553","volume":"101","author":"CP White","year":"2010","unstructured":"White CP, Scott J. Meningococcal serogroup C conjugate vaccination in Canada: how far have we progressed? How far do we have to go? Can J Public Health. 2010;101(1):12\u20134.","journal-title":"Can J Public Health"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12879-015-1015-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1015-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1015-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-015-1015-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,6]],"date-time":"2020-09-06T16:31:17Z","timestamp":1599409877000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcinfectdis.biomedcentral.com\/articles\/10.1186\/s12879-015-1015-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["1015"],"URL":"https:\/\/doi.org\/10.1186\/s12879-015-1015-8","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]},"article-number":"300"}}